Simplex Trading’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.1M | Buy |
29,300
+2,600
| +10% | +$1.21M | 0.01% | 588 |
|
|
2025
Q4 | $12.1M | Buy |
26,700
+5,700
| +27% | +$2.46M | 0.01% | 748 |
|
|
2025
Q3 | $8.22M | Sell |
21,000
-8,100
| -28% | -$3.39M | ﹤0.01% | 1096 |
|
|
2025
Q2 | $13M | Buy |
29,100
+7,300
| +33% | +$3.36M | 0.01% | 731 |
|
|
2025
Q1 | $10.6M | Sell |
21,800
-30,400
| -58% | -$14.2M | 0.01% | 861 |
|
|
2024
Q4 | $21M | Buy |
52,200
+30,300
| +138% | +$14M | 0.01% | 619 |
|
|
2024
Q3 | $10.2M | Sell |
21,900
-22,400
| -51% | -$10.8M | 0.01% | 1023 |
|
|
2024
Q2 | $20.8M | Sell |
44,300
-4,500
| -9% | -$1.95M | 0.01% | 595 |
|
|
2024
Q1 | $20.4M | Sell |
48,800
-73,100
| -60% | -$30.9M | 0.01% | 683 |
|
|
2023
Q4 | $49.6M | Buy |
121,900
+39,400
| +48% | +$14.6M | 0.03% | 350 |
|
|
2023
Q3 | $28.7M | Buy |
82,500
+7,900
| +11% | +$2.76M | 0.02% | 449 |
|
|
2023
Q2 | $26.3M | Buy |
74,600
+12,500
| +20% | +$4.21M | 0.02% | 469 |
|
|
2023
Q1 | $19.6M | Sell |
62,100
-9,100
| -13% | -$2.73M | 0.02% | 595 |
|
|
2022
Q4 | $20.6M | Sell |
71,200
-24,800
| -26% | -$7.56M | 0.02% | 547 |
|
|
2022
Q3 | $27.8M | Buy |
96,000
+41,900
| +77% | +$12.1M | 0.03% | 408 |
|
|
2022
Q2 | $15.2M | Sell |
54,100
-43,100
| -44% | -$11.5M | 0.02% | 622 |
|
|
2022
Q1 | $25.4M | Buy |
97,200
+11,300
| +13% | +$2.68M | 0.02% | 458 |
|
|
2021
Q4 | $18.9M | Buy |
85,900
+24,000
| +39% | +$4.67M | 0.02% | 527 |
|
|
2021
Q3 | $12.5M | Hold |
61,900
| – | – | 0.01% | 628 |
|
|
2021
Q2 | $12.5M | Buy |
61,900
+60,899
| +6,084% | +$12.7M | 0.01% | 615 |
|
|
2021
Q1 | $21.5M | Buy |
+1,001
| New | +$220K | 0.04% | 267 |
|
|
2020
Q2 | – | Sell |
-628
| Closed | -$14.9M | – | 8449 |
|
|
2020
Q1 | $14.9M | Sell |
628
-40
| -6% | -$9.18K | 0.03% | 297 |
|
|
2019
Q4 | $14.6M | Buy |
668
+98
| +17% | +$19.8K | 0.03% | 353 |
|
|
2019
Q3 | $9.66M | Buy |
570
+109
| +24% | +$19.3K | 0.03% | 428 |
|
|
2019
Q2 | $8.45M | Sell |
461
-14
| -3% | -$2.45K | 0.02% | 467 |
|
|
2019
Q1 | $8.74M | Sell |
475
-117
| -20% | -$21.6K | 0.02% | 431 |
|
|
2018
Q4 | $9.81M | Buy |
592
+164
| +38% | +$28.4K | 0.03% | 348 |
|
|
2018
Q3 | $8.25M | Sell |
428
-81
| -16% | -$14.4K | 0.03% | 430 |
|
|
2018
Q2 | $8.65M | Buy |
509
+321
| +171% | +$49.8K | 0.03% | 388 |
|
|
2018
Q1 | $126K | Sell |
188
-1
| -0.5% | -$163 | 0.01% | 1614 |
|
|
2017
Q4 | $46K | Sell |
189
-571
| -75% | -$84.5K | ﹤0.01% | 2539 |
|
|
2017
Q3 | $153K | Buy |
760
+90
| +13% | +$13.5K | 0.01% | 1383 |
|
|
2017
Q2 | $265K | Sell |
670
-586
| -47% | -$70.5K | 0.01% | 1023 |
|
|
2017
Q1 | $92K | Buy |
1,256
+876
| +231% | +$77.1K | ﹤0.01% | 1826 |
|
|
2016
Q4 | $329K | Buy |
380
+1
| +0.3% | +$81 | 0.02% | 760 |
|
|
2016
Q3 | $236K | Buy |
379
+272
| +254% | +$25.7K | 0.02% | 913 |
|
|
2016
Q2 | $63K | Sell |
107
-3
| -3% | -$259 | ﹤0.01% | 1844 |
|
|
2016
Q1 | $264K | Sell |
110
-96
| -47% | -$8.68K | 0.02% | 722 |
|
|
2015
Q4 | $66K | Buy |
206
+20
| +11% | +$2.41K | 0.01% | 1696 |
|
|
2015
Q3 | $208K | Buy |
186
+45
| +32% | +$5.78K | 0.02% | 889 |
|
|
2015
Q2 | $62K | Sell |
141
-128
| -48% | -$16.1K | 0.01% | 1537 |
|
|
2015
Q1 | $180K | Sell |
269
-234
| -47% | -$28K | 0.02% | 770 |
|
|
2014
Q4 | $117K | Buy |
+503
| New | +$56.7K | 0.01% | 849 |
|
Other funds holding VRTX
VCM
VPM
Simplex Trading's VRTX Position: Q1 2026 in Review
Simplex Trading reduced its Vertex Pharmaceuticals (VRTX) stake by 60% in Q1 2026, selling an estimated $984K and leaving 1,401 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #3015.
Simplex Trading first reported a position in VRTX in Q1 2015 and has held it in 30 quarters since. The position peaked at $4.78M in Q1 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Simplex Trading held 1,401 shares of Vertex Pharmaceuticals worth $626K as of Q1 2026.
- Simplex Trading sold 2,110 Vertex Pharmaceuticals shares in Q1 2026, an estimated $984K.
- Vertex Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3015 holding.
- Simplex Trading first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 30 quarters since.
- Simplex Trading's Vertex Pharmaceuticals position peaked at $4.78M in Q1 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.